Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin, Exeltis ink agreement for Bacterial Vaginosis, Trichomoniasis drug SOLOSEC

Ruchika Sharma28 Jan 2022 12:09 PM IST

Solosec is a single-dose therapy for oral use.

DCGI regular market nod to Covaxin, Covishield for adults

Ruchika Sharma28 Jan 2022 12:06 PM IST

New Delhi: India's drug regulator Drugs Controller General of India's (DCGI) on Thursday granted regular market approval for Covid-19 vaccines...

Glenmark bags USFDA nod for Metronidazole Vaginal Gel

Ruchika Sharma28 Jan 2022 11:12 AM IST

Mumbai: Drug maker, Glenmark Pharmaceuticals Inc., USA has received final approval from the United States Food & Drug Administration...

Aurobindo Pharma in trouble for manufacturing lapses at API plant

Ruchika Sharma28 Jan 2022 10:00 AM IST

The USFDA pointed at failure of the company's quality unit to ensure that critical deviations are investigated and resolved.

JB Chemicals to strike Rs 628 crore deal with Sanzyme for probiotic, reproductive brands

Ruchika Sharma27 Jan 2022 1:20 PM IST

Mumbai: J.B. Chemicals & Pharmaceuticals Limited (JBCPL) has recently announced that it will acquire brands for the India market from Sanzyme...

Philips expanded ventilator recall classified as most serious by USFDA

Ruchika Sharma27 Jan 2022 12:45 PM IST

A Philips supplier had incorrectly used a type of polyurethane foam in one of the parts of Trilogy Evo ventilators - an issue that was identified...

Covid-19: Covaxin, Covishield prices likely to be capped at Rs 275 per dose

Ruchika Sharma27 Jan 2022 12:15 PM IST

New Delhi: The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval from India's drug regulator,...

JB Chemicals non-executive director Sanjay Nayar steps down

Ruchika Sharma27 Jan 2022 11:45 AM IST

Mumbai: J. B. Chemicals & Pharmaceuticals Ltd. has recently announced that Mr. Sanjay Nayar, non-executive director, has resigned as a ...

Sun Pharma launches dry eye treatment CEQUA in Canada

Ruchika Sharma27 Jan 2022 11:15 AM IST

Mumbai: Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries Limited today announced the launch of CEQUA, a new...

Glenmark bags USFDA nod for generic version of Ziac Tablets

Ruchika Sharma27 Jan 2022 10:45 AM IST

Mumbai: Glenmark Pharmaceuticals Inc., USA has received final approval from the United States Food & Drug Administration (USFDA) for Bisoprolol...

Cipla Independent Director Naina Lal Kidwai resigns

Ruchika Sharma27 Jan 2022 10:15 AM IST

Mumbai: Cipla has recently announced that Ms. Naina Lal Kidwai, Independent Director of the Company has resigned from the position of...

Medical devices, prescription drugs boost JnJ earning in Q4

Ruchika Sharma27 Jan 2022 9:00 AM IST

Washington: Growing prescription drug and medical device sales nudged Johnson & Johnson past fourth-quarter earnings expectations, and the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok